GlassScriptPhysician profile
Christy L Nolan
NPI 1134440274
$2,738.62
in general payments reported to CMS, 2019-2025
32 companies · $500 in 2025
The $500 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $49.72 · 2021: $200 · 2022: $501 · 2023: $842 · 2024: $380 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,637.25 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $522.28 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $356.42 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $291.21 | 2022-2025 | |
| Exeltis, USA INC. | $194.61 | 2019-2024 | Slynd |
| Baxter Healthcare | $163.72 | 2021 | |
| Sumitomo Pharma America, INC. | $157.94 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $144.97 | 2022-2025 | Zurzuvae |
| Coopersurgical, INC. | $86.11 | 2019-2024 | Wallach Cryosurgical Equipment |
| Merck Sharp & Dohme LLC | $77.62 | 2019-2023 | Gardasil 9 |
| Millicent US INC | $67.95 | 2019-2025 | Femlyv, Intrarosa |
| Organon LLC | $66.21 | 2023-2025 | Jada System, Nexplanon |
| Ascend Therapeutics US, LLC | $53.46 | 2022-2023 | |
| Exact Sciences Corporation | $49.73 | 2023-2025 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $45.20 | 2022 | |
| Novo Nordisk INC | $43.14 | 2023-2024 | Wegovy |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $42.75 | 2022 | |
| Myovant Sciences INC. | $41.79 | 2022 | |
| Pfizer INC. | $36.99 | 2022-2023 | |
| Hill-Rom Company, INC | $36.11 | 2021 | |
| Vertical Pharmaceuticals, LLC | $33.71 | 2019 | |
| Supernus Pharmaceuticals, INC. | $25.60 | 2025 | Qelbree |
| Therapeuticsmd, INC. | $24.19 | 2020-2022 | |
| Roche Diagnostics Corporation | $23.29 | 2019 | |
| Allergan, INC. | $21.80 | 2019 | |
| Olympus America INC. | $19.34 | 2024 | Pk Technology |
| Gynesonics, INC. | $18.93 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $17.81 | 2023 | Coolseal Generator, Myosure Tissue Removal Device, Acessa Provu System |
| Scynexis, INC. | $17.07 | 2022 | |
| Agile Therapeutics, INC. | $16.78 | 2023 | Twirla |
| Smith+Nephew, INC. | $15.36 | 2023 | Pico, Renasys Touch |
| Bayer Healthcare Pharmaceuticals INC. | $14.06 | 2025 | |
| Ethicon US, LLC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.